Mangangot, Mark Caleb R.

HRN: 24-14-40  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2024
CEFUROXIME 750MG (VIAL)
08/12/2024
08/19/2024
IV
200 Mg
Q8H
PCAP-C
Waiting Final Action 
08/15/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
08/15/2024
08/19/2024
PO
1.6ml
OD
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: